Company / Total Assets
MBX Biosciences, Inc. Total Assets History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$268.5M
FY2024
5-year range
$84.2M / $268.5M
FY2023-FY2024
Trend
+219.0%
vs FY2023
Sector context
#188 of 214
Health Care
What the data says
MBX Biosciences, Inc.'s total assets of $269M is lower than 88% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
$269M in FY2024.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 214This company $268.5M Sector average $7.5B
▼
-96.4% below sector average
Key checks
Key Insights
- In FY2024, total assets increased 219.0% year-over-year.
- Ranks #188 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $268.5M | +219.0% |
| FY2023 | $84.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026